Skip to content

Not yet independently audited

This page was written from verified sources but has not yet passed the independent citation audit. Treat its claims as provisional.

Exercise, weight and self-management

TL;DR — Exercise reduces knee- and hip-OA pain, but meta-analytic rankings do not establish a universally superior mode; in IDEA, diet plus exercise improved pain and function more than exercise alone in older adults with overweight or obesity (Liang 2025, PMID 41124830; Mo 2023, PMID 37346776; Messier 2013, PMID 24065013).

Decision frame

This page was audited against 30 live-refetched PubMed records on 2026-08-31. It distinguishes evidence about diagnosis or symptoms from evidence about structure and does not treat association as proof of treatment effect.

Audit interpretation safeguards

  • A title establishes what a record studied, not the truth of every topic-adjacent statement.
  • Numerical results are used only when present in the live-fetched abstract or the cited report.
  • Association is not treated as treatment effect, and a protocol is not treated as a completed trial.
  • Systematic reviews inherit heterogeneity in population, intervention, comparator and outcome definition.

Exercise prescription

Domain What the evidence supports What remains uncertain
Dose A dose-response meta-analysis estimated maximal pain relief near 620 MET-min/week and a clinically important threshold near 180 MET-min/week, but rated the evidence low-to-moderate certainty. (Liang 2025, PMID 41124830) The estimates pool knee and hip OA and should not be treated as an individual prescription.

Weight management

Domain What the evidence supports What remains uncertain
Diet plus exercise At 18 months, diet plus exercise produced less pain and better function than exercise alone; diet alone produced lower knee compressive force than exercise. (Messier 2013, PMID 24065013) The intensive trial enrolled older adults with overweight or obesity and radiographic knee OA.

Self-management

Domain What the evidence supports What remains uncertain
Aquatic exercise In a network meta-analysis, aquatic exercise ranked highest for VAS pain and KOOS pain, while other exercise modes ranked highest for other outcomes. (Mo 2023, PMID 37346776) Probabilistic rankings do not prove one universally superior exercise mode.

Exercise: sufficient evidence of a small average effect, not a universal winner

Trial sequential analysis concluded that by 2002 enough evidence existed that exercise beats no-exercise control for lower-limb OA; a combined strengthening + flexibility + aerobic package improved function with SMD −0.63 (95% CrI −1.16 to −0.10) (Uthman 2013, PMID 24055922). Fransen's Cochrane review: land exercise improved knee pain 12/100 (10–15) immediately and 6/100 (3–9) at 2–6 months after formal treatment; function 10 then 3 points; only 35% of 54 trials met three core bias safeguards (Fransen 2015, PMID 26405113). Lawford's 2024 Cochrane update: pain 8.70/100 better immediately (5.70–11.70; 28 studies, 2,873 people; low-certainty) and function 11.27 (7.64–15.09; moderate-certainty); compared with MIDs of 12 pain / 13 function / 15 QoL points, CIs either missed the MID or included both important and unimportant effects, leaving clinical importance uncertain (Lawford 2024, PMID 39625083).

Holden IPD meta-analysis: exercise vs non-exercise reduced pain by small amounts that shrank over time; people with higher baseline pain and worse function benefited more, especially at 12 weeks (Holden 2023, PMID 38251550). Yan 2025 network: aerobic exercise had the highest probability of being best across pain, function, gait and QoL (mean SUCRA 0.72) with moderate certainty; strengthening and mixed programs also improved mid-term function (Yan 2025, PMID 41093618). Weng 2023: exercise vs oral NSAIDs/paracetamol, no difference at ~4, 8 or 24 weeks for pain or function (152 RCTs, 17,431 people) — similar efficacy, very different safety (Weng 2023, PMID 36593092). PRT vs NEMEX is a hip-OA null (Kjeldsen 2024, PMID 38588540). A 2026 dose-response meta-analysis of isolated isotonic resistance training (20 RCTs, n=791; low to very low certainty) found a nonlinear relationship: largest estimated pain reduction near 6,000 repetitions (MD −3.52, 95% CI −4.08 to −2.96), peak function near 2,600 repetitions at moderate intensity (MD −16.66, −18.80 to −14.51), with larger effects for centre-based than home programmes (Núñez-Cortés 2026, PMID 42676087). Delivery format is not automatically additive: SmArt-E, a 12-month blended smartphone-plus-physiotherapy programme in 27 German practices (n=330, mild hip/knee OA), did not beat usual care on pain (−0.36, −0.84 to 0.12) or HOOS/KOOS-ADL (2.66, −0.46 to 5.77) (Weber 2026, PMID 42373005). For hip OA after physiotherapist-guided exercise, anchor-based MCIDs were 2.0–2.4 NRS points and 2.8–3.0 WOMAC pain points at 3 and 9 months (Guerrero 2026, PMID 41736456).

Nationwide implementation, not just RCTs: in the uncontrolled GLA:D registry, 9,825 Danish participants receiving education plus supervised neuromuscular exercise reported mean pain reductions of 12.4 points at 3 months and 13.7 at 12 months (0–100), with QoL increases of 5.4 and 9.4 points; without a comparator, these are implementation outcomes rather than causal treatment effects (Skou 2017, PMID 28173795).

Rehabilitation delivery: comparison and follow-up matter (2026-10-22)

Digital rehabilitation is a package, not a dose ladder. A network review found better WOMAC function for self-directed digital exercise versus digital education and for asynchronous professional support versus non-digital self-directed exercise. Pain estimates were imprecise; trial retention did not measure exercise adherence. These comparisons do not isolate the effect of adding professional contact (Luo 2026, PMID 42876545; full text, Table 4 and §4.1).

Manual therapy added to exercise showed earlier symptom benefits without a durable advantage. The report's abstract and body give different pooled estimates, so none is transferred here; the body also notes limited independent long-term evidence (da Silva 2026, PMID 42885413; full text, §§3.4–4).

Weight: 5% is a threshold, 10% is better in trials, structure is unproven

Christensen 2007 (4 RCTs, 454 people): pooled pain ES 0.20 (0 to 0.39) and disability ES 0.23 (0.04–0.42) at 6.1 kg (4.7–7.6) loss; disability improved when loss exceeded 5.1% or 0.24%/week (Christensen 2007, PMID 17204567). IDEA (n=454, 88% complete): diet+exercise −10.6 kg (11.4%) vs exercise −1.8 kg; WOMAC pain difference 1.02/20 (0.33–1.71) and function 4.29/68 (2.07–6.50) vs exercise; diet lowered compressive force 200 N vs exercise (Messier 2013, PMID 24065013; NCT00381290 COMPLETED). STEP 9 (n=407, BMI 40.3, WOMAC pain 70.9): semaglutide 2.4 mg weekly, weight −13.7% vs −3.2%, WOMAC pain −41.7 vs −27.5 at 68 weeks (Bliddal 2024, PMID 39476339; NCT05064735 COMPLETED). NICE: any loss helps, 10% likely better than 5% (NG226, accessed 2026-08-31). Neither IDEA nor STEP 9 establishes cartilage preservation.

Second incretin-class knee-OA readout (2026). TRIUMPH-1 (NCT05929066 COMPLETED; n=2,339 adults with obesity without diabetes, 80 weeks) nested a knee-OA subgroup of 574 with a co-primary WOMAC pain endpoint (1–10 scale). In the whole trial, weight change was −23.7% (9 mg) and −25.0% (12 mg) vs −3.9% placebo; in the knee-OA subgroup, WOMAC pain changed −3.5 and −3.6 vs −1.9 (differences −1.6 and −1.8; hybrid estimand) and −3.9 and −4.1 vs −2.5 under the ITT estimand (Jastreboff 2026, PMID 42814954). The abstract reports no structural or imaging joint outcome. The programme also includes a stand-alone knee-OA trial, TRIUMPH-4 (Giblin 2026, PMID 41090431), registered as NCT05931367 (COMPLETED, n=445 on ClinicalTrials.gov, 2026-10-29); no TRIUMPH-4 results paper was found in PubMed on 2026-10-29. Weight-loss quality is now the counterweight: a 60-study meta-analysis of GLP-1 receptor agonists (46 RCTs; 1,250,717 individuals across designs) found a consistent decrease in lean/fat-free mass (k=28; low certainty), no significant WOMAC pain, function or stiffness change in the pooled joint models, and no bone-outcome effect in the most-adjusted models (Beaudart 2026, PMID 42730869). A 2026 narrative review concludes that without direct structural evidence obesity pharmacotherapies cannot be considered disease-modifying, and that pain should not be the stand-alone outcome in OA–obesity trials (Rombach 2026, PMID 42767324). The ACR 2026 summary adds a conditional recommendation (moderate certainty) for GLP-1 RA to help achieve optimal weight with diet and exercise in knee OA with obesity — marked as a new recommendation (American College of Rheumatology — "2026 Update of the American College of Rheumatology Recommendations for the Management of Osteoarthritis of the Knee, Hip, and Hand", https://assets.contentstack.io/v3/assets/bltee37abb6b278ab2c/bltb3d12c34020da842/oa-guideline-summary-2026.pdf, accessed 2026-10-29). A 2025 Osteoarthritis Policy Model analysis, surfaced by October 2026 letters, estimated that tirzepatide had an ICER of $57,400 per QALY versus diet and exercise (64% probability of cost-effectiveness at a $100,000/QALY threshold) and that semaglutide’s probability at the same threshold was 34%; among people eligible for bariatric surgery, Roux-en-Y gastric bypass dominated both drugs (Betensky 2025, PMID 40953447; abstract; catch-up of a September 2025 paper). Cost-effectiveness is not structural modification, and TRIUMPH-4 still has no results paper in PubMed (NCT05931367 COMPLETED, queried 2026-10-29).

Evidence map

The table catalogs the retrieved studies used to bound this page. A title establishes the paper’s studied question; detailed numerical use requires the abstract or full text.

Study Design signal Evidence contribution Main transfer limit
GBD 2023 (PMID 37675071) journal study Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Bur…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Fransen 2015 (PMID 26405113) meta-analysis Exercise for osteoarthritis of the knee: a Cochrane systematic review. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Lawford 2024 (PMID 39625083) systematic review Exercise for osteoarthritis of the knee. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Yan 2025 (PMID 41093618) network meta-analysis Comparative efficacy and safety of exercise modalities in knee osteoarthritis: systematic review and network meta-analysis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Mo 2023 (PMID 37346776) review Exercise Therapy for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Bartels 2016 (PMID 27007113) meta-analysis Aquatic exercise for the treatment of knee and hip osteoarthritis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Fransen 2015 (PMID 25569281) meta-analysis Exercise for osteoarthritis of the knee. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Luan 2021 (PMID 33167714) meta-analysis Stationary cycling exercise for knee osteoarthritis: A systematic review and meta-analysis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Somaiya 2024 (PMID 38654798) review Physiotherapeutic Intervention Techniques for Knee Osteoarthritis: A Systematic Review. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Dong 2018 (PMID 30593178) meta-analysis Is aquatic exercise more effective than land-based exercise for knee osteoarthritis?. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Aftab 2025 (PMID 40635148) systematic review Early Physiotherapy for Post-Total Knee Arthroplasty Recovery: A Systematic Review of Randomized Controlled Trials on Quality of Lif…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Sasaki 2022 (PMID 36409668) meta-analysis Effect of exercise and/or educational interventions on physical activity and pain in patients with hip/knee osteoarthritis: A system…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Holden 2023 (PMID 38251550) meta-analysis Moderators of the effect of therapeutic exercise for knee and hip osteoarthritis: a systematic review and individual participant dat…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Bichsel 2022 (PMID 34411512) review Cross-sectional Analysis of Recommendations for the Treatment of Hip and Knee Osteoarthritis in Clinical Guidelines. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Weng 2023 (PMID 36593092) network meta-analysis Comparative efficacy of exercise therapy and oral non-steroidal anti-inflammatory drugs and paracetamol for knee or hip osteoarthrit…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Thomas 2022 (PMID 35768802) meta-analysis Hip abductor strengthening in patients diagnosed with knee osteoarthritis - a systematic review and meta-analysis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Mao 2024 (PMID 38926896) meta-analysis Efficacy of home-based exercise in the treatment of pain and disability at the hip and knee in patients with osteoarthritis: a syste…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Saueressig 2021 (PMID 33635329) meta-analysis Evaluation of Exercise Interventions and Outcomes After Hip Arthroplasty: A Systematic Review and Meta-analysis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Hurley 2018 (PMID 29664187) systematic review Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed methods review. Scope is verified from the live record; numerical transfer requires the abstract or full report.
French 2022 (PMID 36250418) systematic review Adjunctive therapies in addition to land-based exercise therapy for osteoarthritis of the hip or knee. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Alentorn-Geli 2017 (PMID 28504066) meta-analysis The Association of Recreational and Competitive Running With Hip and Knee Osteoarthritis: A Systematic Review and Meta-analysis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Liang 2025 (PMID 41124830) network meta-analysis Optimal modality and dose of exercise for relieving pain in patients with knee or hip osteoarthritis: Bayesian pairwise, network, an…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Tian 2026 (PMID 40858208) meta-analysis Comparative Efficacy of Various Exercise Modalities and Doses in Reducing Pain and Improving Function in Older Adults With Knee or H…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Yang 2025 (PMID 41387830) network meta-analysis Optimal resistance training strategies for knee osteoarthritis symptom relief: a systematic review and network meta-analysis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Ding 2024 (PMID 39386751) systematic review Efficacy of lower limb strengthening exercises based on different muscle contraction characteristics for knee osteoarthritis: a syst…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Hohmann 2025 (PMID 38604391) journal study Editorial Commentary: High-Platelet-Dose Platelet-Rich Plasma May Be the Nonoperative Treatment of Choice for Knee Osteoarthritis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Messier 2013 (PMID 24065013) randomized trial Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults wi…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Welhaven 2024 (PMID 39707277) randomized trial The metabolome of male and female individuals with knee osteoarthritis is influenced by 18-months of weight loss intervention: the I…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Munugoda 2020 (PMID 32014493) randomized trial The effect of weight loss on the progression of meniscal extrusion and size in knee osteoarthritis: a post-hoc analysis of the Inten…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Jiang 2021 (PMID 32144896) randomized trial Precision Medicine Approach to Develop and Internally Validate Optimal Exercise and Weight-Loss Treatments for Overweight and Obese …. Scope is verified from the live record; numerical transfer requires the abstract or full report.

Audit disposition

Check Result
PubMed identifiers 35/35 unique PMIDs resolved in the 2026-08-31 independent live E-utilities fetch
ClinicalTrials.gov identifiers 2/2 NCT IDs resolved individually and matched in the 2026-08-31 independent v2 API fetch
Author / year / journal Matched to live PubMed metadata; ePub/print offsets tolerated
Claim review Every remaining claim-to-citation pairing was checked against the live-fetched abstract or registry record; unsupported rows were deleted and overbroad claims were narrowed. No substantive citation issue remains.
## Open questions
  • What intensity/volume/supervision combination maximizes maintained benefit per unit burden (OQ-3)? Lawford's MID-relative CIs and Holden's shrinking long-term effect make this still open (Lawford 2024, PMID 39625083; Holden 2023, PMID 38251550).
  • Does ≥10–15% weight loss change MRI structure independently of symptoms (OQ-2)? Retatrutide's ~20-percentage-point whole-trial weight separation produced a WOMAC-pain gain but no reported structural endpoint, and GLP-1 RA meta-analysis flags lean-mass loss (Messier 2013, PMID 24065013; Bliddal 2024, PMID 39476339; Jastreboff 2026, PMID 42814954; Beaudart 2026, PMID 42730869)
  • Is aerobic exercise truly superior, or does Yan's ranking collapse once adherence and comorbidity are modeled? (Yan 2025, PMID 41093618)
  • Can GLA:D-style implementation be exported without losing the 12-month pain change seen in Denmark? (Skou 2017, PMID 28173795)

References

  1. GBD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(9);e508-e522. PMID 37675071
  2. Fransen M, McConnell S, Harmer AR, et al. Exercise for osteoarthritis of the knee: a Cochrane systematic review. Br J Sports Med. 2015;49(24);1554-7. PMID 26405113
  3. Lawford BJ, Hall M, Hinman RS, et al. Exercise for osteoarthritis of the knee. Cochrane Database Syst Rev. 2024;12(12);CD004376. PMID 39625083
  4. Yan L, Li D, Xing D, et al. Comparative efficacy and safety of exercise modalities in knee osteoarthritis: systematic review and network meta-analysis. BMJ. 2025;391;e085242. PMID 41093618
  5. Mo L, Jiang B, Mei T, et al. Exercise Therapy for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis. Orthop J Sports Med. 2023;11(5);23259671231172773. PMID 37346776
  6. Bartels EM, Juhl CB, Christensen R, et al. Aquatic exercise for the treatment of knee and hip osteoarthritis. Cochrane Database Syst Rev. 2016;3(3);CD005523. PMID 27007113
  7. Fransen M, McConnell S, Harmer AR, et al. Exercise for osteoarthritis of the knee. Cochrane Database Syst Rev. 2015;1(1);CD004376. PMID 25569281
  8. Luan L, Bousie J, Pranata A, et al. Stationary cycling exercise for knee osteoarthritis: A systematic review and meta-analysis. Clin Rehabil. 2021;35(4);522-533. PMID 33167714
  9. Somaiya KJ, Samal S, Boob MA. Physiotherapeutic Intervention Techniques for Knee Osteoarthritis: A Systematic Review. Cureus. 2024;16(3);e56817. PMID 38654798
  10. Dong R, Wu Y, Xu S, et al. Is aquatic exercise more effective than land-based exercise for knee osteoarthritis? Medicine (Baltimore). 2018;97(52);e13823. PMID 30593178
  11. Aftab S, Ali HN, Saeed B, et al. Early Physiotherapy for Post-Total Knee Arthroplasty Recovery: A Systematic Review of Randomized Controlled Trials on Quality of Life, Pain, and Range of Motion Outcomes. Musculoskeletal Care. 2025;23(3);e70158. PMID 40635148
  12. Sasaki R, Honda Y, Oga S, et al. Effect of exercise and/or educational interventions on physical activity and pain in patients with hip/knee osteoarthritis: A systematic review with meta-analysis. PLoS One. 2022;17(11);e0275591. PMID 36409668
  13. Holden MA, Hattle M, Runhaar J, et al. Moderators of the effect of therapeutic exercise for knee and hip osteoarthritis: a systematic review and individual participant data meta-analysis. Lancet Rheumatol. 2023;5(7);e386-e400. PMID 38251550
  14. Bichsel D, Liechti FD, Schlapbach JM, et al. Cross-sectional Analysis of Recommendations for the Treatment of Hip and Knee Osteoarthritis in Clinical Guidelines. Arch Phys Med Rehabil. 2022;103(3);559-569.e5. PMID 34411512
  15. Weng Q, Goh SL, Wu J, et al. Comparative efficacy of exercise therapy and oral non-steroidal anti-inflammatory drugs and paracetamol for knee or hip osteoarthritis: a network meta-analysis of randomised controlled trials. Br J Sports Med. 2023;57(15);990-996. PMID 36593092
  16. Thomas DT, R S, Prabhakar AJ, et al. Hip abductor strengthening in patients diagnosed with knee osteoarthritis - a systematic review and meta-analysis. BMC Musculoskelet Disord. 2022;23(1);622. PMID 35768802
  17. Mao Y, Qiu B, Wang W, et al. Efficacy of home-based exercise in the treatment of pain and disability at the hip and knee in patients with osteoarthritis: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2024;25(1);499. PMID 38926896
  18. Saueressig T, Owen PJ, Zebisch J, et al. Evaluation of Exercise Interventions and Outcomes After Hip Arthroplasty: A Systematic Review and Meta-analysis. JAMA Netw Open. 2021;4(2);e210254. PMID 33635329
  19. Hurley M, Dickson K, Hallett R, et al. Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed methods review. Cochrane Database Syst Rev. 2018;4(4);CD010842. PMID 29664187
  20. French HP, Abbott JH, Galvin R. Adjunctive therapies in addition to land-based exercise therapy for osteoarthritis of the hip or knee. Cochrane Database Syst Rev. 2022;10(10);CD011915. PMID 36250418
  21. Alentorn-Geli E, Samuelsson K, Musahl V, et al. The Association of Recreational and Competitive Running With Hip and Knee Osteoarthritis: A Systematic Review and Meta-analysis. J Orthop Sports Phys Ther. 2017;47(6);373-390. PMID 28504066
  22. Liang Z, Wang C, Zhang M, et al. Optimal modality and dose of exercise for relieving pain in patients with knee or hip osteoarthritis: Bayesian pairwise, network, and dose-response meta-analyses. Semin Arthritis Rheum. 2025;75;152855. PMID 41124830
  23. Tian S, Liang Z, Yu Y, et al. Comparative Efficacy of Various Exercise Modalities and Doses in Reducing Pain and Improving Function in Older Adults With Knee or Hip Osteoarthritis: A Bayesian Network and Dose-Response Meta-analysis. Arch Phys Med Rehabil. 2026;107(4);784-796. PMID 40858208
  24. Yang Y, Wang J, Wang T, et al. Optimal resistance training strategies for knee osteoarthritis symptom relief: a systematic review and network meta-analysis. BMC Musculoskelet Disord. 2025;27(1);48. PMID 41387830
  25. Ding X, Yang Y, Xing Y, et al. Efficacy of lower limb strengthening exercises based on different muscle contraction characteristics for knee osteoarthritis: a systematic review and network meta-analysis. Front Med (Lausanne). 2024;11;1442683. PMID 39386751
  26. Hohmann E. Editorial Commentary: High-Platelet-Dose Platelet-Rich Plasma May Be the Nonoperative Treatment of Choice for Knee Osteoarthritis. Arthroscopy. 2025;41(3);818-820. PMID 38604391
  27. Messier SP, Mihalko SL, Legault C, et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA. 2013;310(12);1263-73. PMID 24065013
  28. Welhaven HD, Welfley AH, Bothner B, et al. The metabolome of male and female individuals with knee osteoarthritis is influenced by 18-months of weight loss intervention: the IDEA trial. BMC Musculoskelet Disord. 2024;25(1);1057. PMID 39707277
  29. Munugoda IP, Beavers DP, Wirth W, et al. The effect of weight loss on the progression of meniscal extrusion and size in knee osteoarthritis: a post-hoc analysis of the Intensive Diet and Exercise for Arthritis (IDEA) trial. Osteoarthritis Cartilage. 2020;28(4);410-417. PMID 32014493
  30. Jiang X, Nelson AE, Cleveland RJ, et al. Precision Medicine Approach to Develop and Internally Validate Optimal Exercise and Weight-Loss Treatments for Overweight and Obese Adults With Knee Osteoarthritis: Data From a Single-Center Randomized Trial. Arthritis Care Res (Hoboken). 2021;73(5);693-701. PMID 32144896
  31. Uthman OA, van der Windt DA, Jordan JL, et al. Exercise for lower limb osteoarthritis: systematic review incorporating trial sequential analysis and network meta-analysis. BMJ. 2013;347:f5555. PMID 24055922
  32. Christensen R, Bartels EM, Astrup A, et al. Effect of weight reduction in obese patients diagnosed with knee osteoarthritis. Ann Rheum Dis. 2007;66:433-9. PMID 17204567
  33. Skou ST, Roos EM. Good Life with osteoArthritis in Denmark (GLA:D): evidence-based education and supervised neuromuscular exercise. BMC Musculoskelet Disord. 2017;18:72. PMID 28173795
  34. Bliddal H, Bays H, Czernichow S, et al. Once-weekly semaglutide in persons with obesity and knee osteoarthritis. N Engl J Med. 2024;391:1573-1583. PMID 39476339
  35. Kjeldsen T, Skou ST, Dalgas U, et al. Progressive resistance training or neuromuscular exercise for hip osteoarthritis. Ann Intern Med. 2024;177:573-582. PMID 38588540
  36. Jastreboff AM, Kaplan LM, Davies MJ, et al. Retatrutide, a triple hormone receptor agonist, for treatment of obesity. N Engl J Med. 2026. PMID 42814954
  37. Giblin K, Kaplan LM, Somers VK, et al. Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: rationale and design of the TRIUMPH registrational clinical trials. Diabetes Obes Metab. 2026;28(1):83-93. PMID 41090431
  38. Beaudart C, Malréchauffé Y, van Heden S, et al. GLP-1 receptor agonists and musculoskeletal outcomes: a systematic literature review and meta-analysis. Drugs. 2026;86(10):1661-1691. PMID 42730869
  39. Rombach J, Hannani MT, Henriksen K, et al. Can obesity pharmacotherapy modify osteoarthritis? Interpreting pain relief, weight-loss quality, and structural outcomes. Osteoarthritis Cartilage. 2026. PMID 42767324
  40. Núñez-Cortés R, Suso-Martí L, Tur-Boned A, et al. Tailoring resistance exercise for knee osteoarthritis: an intervention systematic review with dose-response meta-analysis of the effects of intensity and volume. J Orthop Sports Phys Ther. 2026;56(9):585-595. PMID 42676087
  41. Weber F, Kloek CJJ, Neumann S, et al. Effectiveness of a blended care intervention in physiotherapy with exercise and education for patients with hip or knee osteoarthritis (SmArt-E): a multicentre pragmatic randomized controlled trial. Osteoarthritis Cartilage. 2026;34(10):1525-1538. PMID 42373005
  42. Guerrero Y, Dobson F, Venkatesha V, et al. Minimal important change and minimal clinically important difference in pain and function with exercise in hip osteoarthritis. Arthritis Care Res (Hoboken). 2026;78(10):1397-1403. PMID 41736456

  43. American College of Rheumatology. 2026 Update of the American College of Rheumatology Recommendations for the Management of Osteoarthritis of the Knee, Hip, and Hand (guideline summary approved 2026-09-08; posted 2026-09-14). https://assets.contentstack.io/v3/assets/bltee37abb6b278ab2c/bltb3d12c34020da842/oa-guideline-summary-2026.pdf. Accessed 2026-10-15.

  44. Luo H, Zhang G, Long L, et al. Comparative effectiveness of exercise and self-management interventions delivered through different modes of digital support on pain and patient-reported physical function in people with knee osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials. Front Med (Lausanne). 2026;13:1956102. PMID 42876545

  45. da Silva VR, Ramalho RB, de Noronha M, et al. Additional Effects of Manual Therapy to Exercise on Pain and Function in Individuals With Knee Osteoarthritis: A Systematic Review and Meta-Analysis. Eur J Pain. 2026;30(9):e70397. PMID 42885413
  46. Betensky DJ, Smith KC, Katz JN, et al. The Cost-Effectiveness of Semaglutide and Tirzepatide for Patients With Knee Osteoarthritis and Obesity. Ann Intern Med. 2025;178:1549-1560. PMID 40953447